Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.020
+0.051 (5.30%)
At close: May 12, 2025, 4:00 PM
0.8001
-0.2200 (-21.56%)
After-hours: May 12, 2025, 7:35 PM EDT
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $118.24 million as of May 12, 2025. Its market cap has decreased by -48.07% in one year.
Market Cap
118.24M
Enterprise Value
301.18M
1-Year Change
-48.07%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $118.24M, a decrease of -70.75%. That is a compound annual growth rate of -11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 112.30M | -29.37% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |